Scholars Crossing
Faculty Publications and Presentations

Department of Biology and Chemistry

2009

Direct Binding of Cytosolic NDP Kinases to Membrane Lipids is
Regulated by Nucleotides
Kimberly A. P. Mitchell
Liberty University, kamitchell@liberty.edu

Gabor Szabo
Angela de S . Otero

Follow this and additional works at: https://digitalcommons.liberty.edu/bio_chem_fac_pubs
Part of the Biology Commons, and the Chemistry Commons

Recommended Citation
Mitchell, Kimberly A. P.; Szabo, Gabor; and Otero, Angela de S ., "Direct Binding of Cytosolic NDP Kinases
to Membrane Lipids is Regulated by Nucleotides" (2009). Faculty Publications and Presentations. 103.
https://digitalcommons.liberty.edu/bio_chem_fac_pubs/103

This Article is brought to you for free and open access by the Department of Biology and Chemistry at Scholars
Crossing. It has been accepted for inclusion in Faculty Publications and Presentations by an authorized
administrator of Scholars Crossing. For more information, please contact scholarlycommunications@liberty.edu.

REVISED Manuscript (text UNmarked)

DIRECT BINDING OF CYTOSOLIC NDP KINASES TO
MEMBRANE LIPIDS IS REGULATED BY NUCLEOTIDES

Kimberly A. P. Mitchell, Gabor Szabo* and Angela de S .Otero
Department of Molecular Physiology and Biological Physics
University of Virginia Medical School
Charlottesville, VA

*Corresponding author
Gabor Szabo
Department of Molecular Physiology and Biological Physics
University of Virginia Medical School
P.O. Box 800736, Charlottesville, VA 22908-0736
E-mail: gs3z@virginia.edu
Fax: (434) 982-1616
Keywords: nucleoside-diphosphate kinase, nm23, cytosol, membranes, phospholipids,
nucleotides

SUMMARY
In spite of their complete lack of any structural features that characterize
membrane proteins, cytosolic nucleoside-diphosphate kinases (NDPKs) have been found
repeatedly to associate with membranes. In some instances the recruitment of cytosolic
NDPKs to membranes was attributed to interactions with peripheral or integral
membrane proteins, but in many cases the mechanism underlying the association of
NDPKs with membranes remained unknown. We show here that cytosolic NDPKs bind
directly to membrane lipids in a dynamic process that is controlled by its substrates,
nucleoside tri- and diphosphates, and can be fully reconstituted with chemically defined,
protein-free phospholipids and recombinant NDPK, or with purified NDPK. Our results
uncover a novel mechanism for the reversible targeting of soluble NDPKs to membranes,
where they may act as a reservoir of high energy phosphate, supporting the operation of
membrane-based processes that utilize nucleotides other than ATP, such as intracellular
traffic and phospholipid biosynthesis.
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1. INTRODUCTION
Nucleoside-diphosphate kinases (NDPKs) play a central role in a broad range of
cellular functions, including nucleic acid synthesis, lipid, and carbohydrate metabolism,
through their ability to phosphorylate nucleoside diphosphates utilizing the terminal
phosphate of ATP [1,2]. These enzymes show broad base specificity, but display a
preference for adenine and guanine nucleotides. The phosphate transfer requires Mg2+
and follows ping-pong kinetics [3], taking place via a phosphohistidine intermediate. The
reaction occurs in two steps,
E+ N1TPE∙N1TPE~P+N1DP

(a)

E~P+N2DPE~P∙N2DPE+N2TP

(b)

that combined give the overall reaction sequence:
N1TP+N2DP  N1DP+N2TP

(1)

The most ubiquitous members of this family of proteins, NDPK A and B (the
products of the nm23-1 and -2 genes), are hexamers of two highly (88%) homologous
polypeptides of ~20 kDa [4], with similar kinetic parameters [5]. NDPK A and B are
abundant proteins: their estimated cytosolic concentration ranges from 1 to 10 M. While
human NDPK A and B differ markedly in isoelectric point (theoretical pI values are 5.8
and 8.5 for A and B, respectively), their murine equivalents have pIs around 7. The threedimensional structures for human NDPK A and B are very similar [6,7], and the
monomers of the two proteins can associate, forming hetero-hexamers [4].
NDPK A and B have all the characteristics of cytosolic proteins, with no exposed
hydrophobic

segments

or

membrane-binding

motifs.

Yet,

purification

and

characterization of NDPK from rat liver plasma membranes reveal that it is identical to
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the soluble protein [8]. Indeed, in many instances cytosolic NDPKs associate with
membranes of a wide variety of intracellular compartments. At the plasma membrane
NDPKs influence the function of ion channels [9], receptor activation and desensitization
by agonists [10], activation of phagocyte NADPH oxidase [11], dynamin-mediated
endocytosis [12-14] and integrin-mediated adhesion [15]. Soluble NDPKs also localize to
endosomes [14], membranes from the endoplasmic reticulum [16-19], the Golgi and
vesicles budding from the trans-Golgi [16], as well as phagosomes [20]. In some cases
the recruitment of cytosolic NDPKs to membranes was ascribed to interactions with
peripheral or integral membrane proteins such as G proteins [21-23], integrin cytoplasmic
domain associated protein 1- [15], the SET complex [17] and the potassium channel
KCa3.1 [9]. Overexpression of cytosolic NDPKs revealed novel associations with the
GTP-bound form of ARF6 [13], the thromboxane A2  receptor [10] and the von-Hippel
Lindau protein [14], and these binding partners were proposed to anchor NDPK to
membranes. Recently, NDPKs A and B were found to associate directly with purified
phospholipids [19, 24].
Intracellular transport of membranes is largely mediated by the microtubular
network, and treatment of cellular extracts with taxol, followed by pelleting of the
resulting microtubules and associated structures, allows the rapid isolation and
characterization of a fraction enriched in trafficking vesicles. This fraction (MT/Ves) has
been well characterized, and contains microtubules to which are tethered endosomes,
exocytic and transcytotic vesicles, as well as putative intra-Golgi transport vesicles [2528]. We have previously shown that NDPK is present in MT/Ves and that NDPK binds to
the membranes in this fraction, but not to the microtubules [28]. Furthermore, the binding
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of NDPK to intracellular membranes is disrupted by high concentrations of nucleotides,
with an order of selectivity typical of NDPKs. The present work seeks to further
characterize the association of NDPK with the intracellular vesicles isolated by
microtubule stabilization. The results indicate that NDPK is present in most of the
membrane vesicles obtained in this manner. Additionally, it is eluted from these
membranes by nucleotides not as a complex, but as a single protein, and this is a
reversible process: as nucleotide concentrations are reduced to micromolar levels, NDPK
re-binds to membranes. Thus, the levels of nucleotides in the cell have a profound effect
on the reversible interaction of soluble NDPKs with membranes. Furthermore, the
nucleotide sensitivity of this process is a consequence of the intrinsic properties of NDPK
and can be replicated in a simple system consisting of purified soluble NDPKs and
chemically defined phospholipids. Taken together, our observations reveal a simple and
novel mechanism for the reversible targeting of soluble NDPKs to the membranes of
intracellular transport vesicles, and support the hypothesis that NDPK may play a role in
localized regeneration of nucleotides such as CTP and GTP, that are essential for the
biosynthesis of phospholipids as well as intracellular traffic.
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2. MATERIALS AND METHODS
2.1. Materials
Nucleotides were from Roche (GTP, GTPS, GMP-PNP) and Sigma-Aldrich
(ATP, ADP, GDPS). Taxol was purchased from Tocris, Sigma-Aldrich or LC
Laboratories. SDS-PAGE gels (NuPage, 10 or 12%, run in MOPS/SDS buffer) were from
Invitrogen. PIP strips were from Echelon Biosciences. Anti-nm23 H1/2/3, anti-Arf6,
and anti-von Hippel-Lindau protein were from Santa Cruz Biotechnology, anti-NDPK
(Ab-1) and anti--tubulin (Ab-2) from LabVision, anti-dynamin from Calbiochem,
antibodies to Rac1 were from Santa Cruz and Upstate Biotechnology (clone 23A8).
Polyclonal antibodies to NDPK C (Anti-C), affinity-purified antibodies to NDPK A
depleted of antibodies cross-reacting with NDPK B (Anti-A), and affinity-purified
polyclonal antibodies to NDPK B were a generous gift of Dr. Ioan Lascu (Université de
Bordeaux, France). For specific detection of NDPK B, IgGs cross-reacting with NDPK A
were removed by chromatography on columns of immobilized NDPK A [29]; the fraction
obtained is designated here as Anti-B. Other antibodies were from sources previously
described [28]. Secondary antibodies labeled with infrared dyes (IRDye 800 anti-rabbit
and anti-goat, IRDye700 anti-mouse) were from Rockland Immunochemicals.
Phospholipids (dioleolylphosphatidylcholine (DOPC), dioleoylphosphatidylethanolamine
(DOPE),

dioleoylphosphatidylserine

(DOPS),

1,2-dioleoyl-sn-glycerol-3-phosphate

(DOPA), and carboxyfluorescein-labeled dioleoylphosphatidylethanolamine) were from
Avanti Polar Lipids.
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2.2 Methods
Cell Culture
NIH-3T3 fibroblasts were cultured in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate,
100 U/l penicillin and 100 µg/ml streptomycin at 37 °C in a humidiﬁed 5% CO2
atmosphere. For ATP depletion experiments, cultures were transferred to low glucose
medium, and were either left untreated in controls, or exposed to 50 mM 2-deoxyglucose
and 10 mM sodium azide for 1h.
Isolation of microtubule-associated vesicles and cytosol
Microtubule-associated vesicles (MT/Ves) were isolated as described previously
[28]. Briefly, NIH-3T3 cells were homogenized in MEPS (35 mM PIPES pH 7.1 with
NaOH, 5 mM MgSO4, 5 mM EGTA, 200 mM sucrose, 1 mM DTT; the calculated free
Mg2+ is 4.3 mM) containing protease inhibitors (2 mM PMSF, 1 mM benzamidine, 2
g/ml leupeptin). A post-nuclear supernatant (S1) was centrifuged at 40,000 xg for 20
min. The supernatant (S2; small vesicles and cytosol) was incubated at 37 °C for 30 min
with 20 µM taxol (and nucleotides when indicated) to polymerize tubulin, and pelleted at
16,000 xg for 30 min at 4 °C. The pellets were brought to the original volume with
MEPS, taxol was added to 20 M and the samples were centrifuged at 16,000 xg. After a
second wash, the pellets were solubilized in SDS-PAGE sample buffer and analyzed by
SDS-PAGE and immunoblotting. In some instances the pellets were incubated with
nucleotides after two washes, and then processed for analysis. Samples were
immunoblotted in parallel with antibodies to -tubulin (and Rab4 or LAMP1, when
appropriate) to make sure that treatments did not affect tubulin polymerization or copelleting of membrane vesicles. Proteins were detected by chemiluminescence and
7

quantitated with Maxim DL 2.12 (Diffraction Limited) software, or with the LI-COR®
Odyssey infrared imaging system. Results shown are representative of 3-10 separate
experiments. Cytosol from NIH-3T3 cells was prepared by centrifugation of the S2
supernatant in a TLA 100.3 rotor at 335,000 xg for 1 h at 4 °C.
Immunofluorescence and Confocal Microscopy
A 10 l aliquot of MT/Ves pellet suspended in MEPS was spread onto polylysinecoated coverslips and allowed to adhere for 3 min. The specimen was fixed with 4%
paraformaldehyde for 10 min, washed three times with PBS, incubated with NaBH4 to
quench free aldehyde groups and processed for indirect immunofluorescence as in [28],
using an antibody to NDPK (Ab-1; 1:50), followed by Texas Red anti-rabbit (1:100).
Confocal and differential interference contrast (DIC) images were acquired with an
Olympus FluoView 300 confocal laser scanning microscope (Olympus, Center Valley,
PA).
Purification of NDPK from human erythrocytes
Soluble NDPK was purified from human erythrocytes using a modification of an
earlier protocol [30]. Briefly, red blood cells were lysed in buffer A (25 mM MOPS, 1
mM EDTA, 1 mM PMSF, pH 7.5) on ice, and centrifuged at 17,600 xg for 1h. The
supernatant was removed and fractionated with 45%-85% ammonium sulfate. The 85%
precipitate was suspended in buffer B (20 mM Tris, 1 mM EDTA, pH 8.0), dialyzed to
the same buffer, concentrated on an Amicon XM50 membrane, centrifuged for 15 min at
48,000 xg, and applied to a Reactive Yellow 3 column. Wash and elution with ATP were
as described [30], and yielded a mix of NDPKs A and B estimated to be 88% pure by
SDS-PAGE, with a specific activity of 1,200 U/mg when tested by the coupled assay
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with 1 mM ATP and 0.2 mM TDP as substrates [30]. The purified preparation (eNDPK)
was stored at -20 °C in PBS/50% glycerol.
Bacterial expression and purification of human NDPK A
Wild-type NDPK A was expressed in E. coli from a pET 21b vector generously
provided by Dr. Marie-Lise Lacombe (INSERM U 402, Paris, France), as described [31].
Purification was by sequential chromatography in Q-Sepharose and Blue Sepharose as
described by Lascu et al. [32]. After concentration and desalting the preparation was
stored in liquid nitrogen. The purified protein (rNDPK A) was electrophoretically
homogeneous and had a specific activity of 1600 U/mg.
Size Exclusion Chromatography
MT/Ves pellets were isolated, and incubated as described above in MEPS buffer
with 20 µM taxol, with or without 1 mM GTP. After centrifugation at 16,000 xg the
supernatant was removed and applied to a Superose 12 HR 10/30 (Amersham
Biosciences) column developed with MEPS buffer at a flow rate of 0.4 ml/min and
fractions of 1.0 ml were collected. The protein elution profile was monitored at 280 nm,
and aliquots were assayed for NDPK activity. The samples were precipitated with
trichloroacetic acid, dissolved in sample buffer and analyzed by SDS-PAGE followed by
silver staining and/or immunoblotting. The column was calibrated with standards (IgG,
BSA, -lactoglobulin, cytochrome C and vitamin B12) according to the manufacturer's
instructions. In earlier experiments we utilized a Sepharose 6 HR 10/30 column with
similar results.
Lipid overlay assay
Nitrocellulose membranes pre-spotted with phospholipids (PIP strips) were
9

blocked for 1 h at 25°C with 3% fatty-acid free bovine serum albumin in Tris-buffered
saline with 0.1% Tween-20 (TBST). Blots were overlaid with 4 ml of 3.75 g/ml purified
rNDPK A in blocking solution, with or without 1 mM GTP, for 1h at 4 °C. The
membranes were washed 6 times for 5 min with TBST, and then incubated with primary
antibody against NDPK for 1 h. After 4 washes, the blot was incubated with secondary
antibody, washed 4 more times, and developed using enhanced chemiluminescence. The
same procedure was followed with cytosol from NIH-3T3 cells.
Liposome Binding Assays
The lipid combinations used were (in molar ratios): DOPC:DOPS, DOPC:DOPE
and DOPC:DOPA (80:20), and DOPC:DOPE:DOPS, DOPC:DOPE:DOPA (60:20:20).
Small unilamellar vesicles were prepared by mixing the appropriate combination of lipid
stock solutions in chloroform in a glass tube. The solvent was evaporated under a stream
of nitrogen and the samples were further dried in a SpeedVac for 1 h. Lipids (1.8 mol)
were resuspended in a vortex mixer with 90 l of MEPS buffer with 400 mM sucrose,
incubated for 1h at room temperature and sonicated on ice in a bath sonicator (Model
G112SPIT, Laboratory Supply Company, Hicksville, NY) for 8-12 min. Prior to
experiments, cytosol or purified proteins were diluted in MEPS with 100 mM sucrose and
centrifuged in a Beckman Airfuge at 167,000 xg for 10 min to remove any aggregates.
Cytosol (1.5-1.8 mg/ml) or purified NDPK (0.8-5 M) were incubated with liposomes
(0.4 mg/ml) at 30 °C for 30 min. After centrifugation at 200,000 xg for 30 min at 25 °C
in a TLA 120.1 rotor, the supernatants were removed and the pellets were resuspended in
MEPS buffer with or without 1 mM GTP. The samples were incubated for 30 min at 30
°C and pelleted as above. The supernatants and pellets were resolved by SDS-PAGE and
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immunoblotted. Lipid recovery was uniform, as established using carboxyfluoresceinlabeled phosphatidylethanolamine (0.2 mol %) as a marker. All results shown are
representative of 3-6 separate experiments.
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3. RESULTS
We have previously shown that nucleoside diphosphate kinase (NDPK) co-purifies
with intracellular vesicles associated with taxol-stabilized microtubules (MT/Ves), but
dissociates from this fraction upon incubation with 1 mM GTP or ATP [28]. Guanine
nucleotide analogs also elute NDPK from membranes: at 1 mM, GTPS and GDPS are
as effective as GTP, whereas GMP-PNP induces only a partial release. This order of
efficacy is not the one expected from the binding site of GTP-binding proteins, where
GTPS and GMP-PNP act alike, and have opposite effects to those of GDPS. Rather, it
parallels the rank order of affinity of these compounds for NDPK, leading to the
suggestion that the nucleotide binding site involved in the dissociation process is that of
NDPK [28]. The simplest interpretation of this behavior is that binding of nucleotides to
the active site triggers the dissociation of NDPK from its binding site in the vesicles. On
the other hand, nucleotides often disrupt interactions between microtubules, motors and
their membrane cargo [33-35]. We found that dynein and kinesin, as well as Rab4 and
Lamp1, remained in the pellet after treatment with 1 mM GTP or ATP [28], suggesting
that the association of motors plus early and late endosomal membranes with
microtubules was intact. However, the elution of NDPK by nucleotides could be linked to
the release of yet another component of the fraction.
3.1. NDPK is the main protein released from membranes by GTP
To determine whether 1 mM GTP dissociated other components concomitantly
with NDPK, we washed MT/Ves pellets in MEPS buffer with or without 1 mM GTP,
centrifuged the samples and examined the protein composition of the supernatants by
SDS-PAGE followed by silver staining and immunoblotting. A prominent band
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migrating at the position expected for NDPK (~18 kDa) is present in the GTP extract, but
not in the control (Fig. 1A, arrow). Aside from this band, the protein profiles of control
and GTP extracts are essentially the same. Immunoblotting with antibodies to NDPKs A,
B and C indicated that this band consists mostly of NDPK B (Fig. 1B), which is
expressed at higher levels in murine tissues than other isoforms [16], as well as trace
amounts of NDPK A. NDPK C is detectable only in the cell lysate.
3.2. NDPK is released as an active hexamer, without associated proteins
To confirm the identity of this protein as NDPK, the supernatants obtained in the
presence of GTP were further analyzed by size-exclusion chromatography, and the
NDPK content of individual fractions was measured using enzyme activity assays, SDSPAGE and immunoblotting. As seen in Figure 1C, the GTP extract contains NDPK
activity that elutes in one peak centered at approximately 100 kDa, the size expected for a
hexamer of 18 kDa subunits. The enzyme activity overlaps with a band identifiable as
NDPK by immunoblotting (Fig. 1D). A similar analysis of control extracts shows no
NDPK activity above basal levels and no reactivity with antibodies to NDPK in
immunoblots (not shown). These experiments verify that the 18 kDa band seen in Figure
1A is NDPK, and show that GTP releases enzymatically active NDPK, in its native,
hexameric state. Moreover, the apparent molecular mass of 100 kDa demonstrates that
NDPK is released alone, and not in a complex with other proteins.
We also performed immunoblot analyses of the MT/Ves pellet with antibodies
against known NDPK binding partners, such as Arf6, dynamin, Rac1, and the von
Hippel-Lindau protein. Only Rac1 and Arf6 were detected in the MT/Ves pellet, and
neither was released upon nucleotide treatment (not shown). In addition, although [-
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32

P]-GTP overlay assays of the MT/Ves fraction revealed the presence of several small

GTP binding proteins, none were released by GTP treatment (not shown).
3.3. The binding of NDPK to intracellular vesicles is controlled by its catalytic cycle
GTP, ATP and the thiophosphate analogues GTPS and GDPS, which bind
tightly to NDPKs [5] release similar amounts of NDPK from the MT/Ves fraction,
whereas GMP-PNP, which binds with low affinity to NDPK, is far less effective [28].
This suggests that the nucleotide effects on the association of NDPK to membranes are
intimately linked to its catalytic properties. To address this issue in depth, we determined
the dose-response relationships for release of NDPK from the MT/Ves fraction by GTP,
ATP, ADP, GTPS and GDPS.
As the concentration of GTP or ATP increases from 1 M to 1 mM, the amounts
of NDPK bound to the MT/Ves pellet in the presence of GTP or ATP decreases markedly
(Fig. 2A). GTPS and GDPS inhibit binding in a dose-dependent manner and with
significantly higher potency than ATP or GTP. In contrast, ADP decreases the amount of
NDPK bound by 70-80% at all concentrations tested.
While the results obtained at high concentrations of nucleotides confirm our
previous data on the dissociation of NDPK from membranes, examination of the effects
of low concentrations of these compounds offers a new insight into the association
process. Unexpectedly, the lowest concentration of GTP and ATP, 1 M, consistently
raised the amount of NDPK associated with MT/Ves to 120-125% of the control value.
This increase is not observed with the GTP analog GTPS which binds to NDPK with
relatively high affinity, but is a poor substrate for phosphate transfer [5], and suggests
that only nucleotides that transfer phosphate to NDPK can promote the association of
14

NDPK with membranes. If so, reducing the concentration of E~P should promote
dissociation. Indeed, ADP, which is an acceptor for the phosphate of E~P and thus
dephosphorylates the enzyme, induces dissociation even at 1 M. In contrast, at 1 M,
GDPS, which is a poor phosphate acceptor, has little or no effect on the association of
NDPK with membranes. Collectively, these data indicate that the association of NDPK
with intracellular vesicles is a reversible process whose dynamics are controlled by the
relative amounts of the phosphorylated intermediate, E~P, and the free enzyme, E.
If this reasoning is correct, a reduction in the [NTP]/[NDP] ratio in cells, which
necessarily decreases the [E~P]/[E] ratio, should decrease significantly the amounts of
NDPK bound to MT/Ves. To test this hypothesis, we assessed the levels of NDPK in
MT/Ves fractions isolated from cells pre-incubated with the glycolysis inhibitor 2deoxyglucose and the mitochondrial poison sodium azide (D/A), a treatment that
markedly depletes cytosolic ATP (and consequently other NTPs), and reduces markedly
the [ATP]/[ADP] ratio, as well as the levels of free ATP and GTP [36]. Figure 2B shows
that MT/Ves pellets prepared from cells pre-treated with D/A contain only traces of
NDPK (7±5 % of control, n=4), as would be expected if the association of NDPK to
MT/Ves depended on the levels of ATP. There is, however, the possibility that the
decrease in binding is due to a secondary effect of the D/A treatment, which could
decrease the number of NDPK binding sites on the MT/Ves fraction or induce a decline
in the actual amounts of cytosolic NDPK. To address this point, we performed several
control experiments: in one, we incubated MT/Ves pellets obtained from D/A-treated
cells with cytosol from the control cells, centrifuged the preparation and measured NDPK
in the pellet. This same procedure was repeated using cytosol from D/A-treated cells, and
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from control cells, which were incubated with MT/Ves pellets that had been stripped of
NDPK with 1 mM GTP and therefore contain significant amounts of residual GTP. The
results in Figure 2B show that in all cases NDPK re-bound to the MT/Ves fraction. This
set of experiments indicates that both MT/Ves membranes and cytosolic NDPK from
D/A-treated cells retain their ability to associate, as long as the NTP concentration in the
incubation mixture is at a minimum level. Therefore, the lower binding of NDPK to
MT/Ves isolated from cells treated with D/A is likely to be the consequence of a lowered
[ATP]/[ADP] ratio.
3.4. NDPK localizes to the majority of vesicular structures associated with MT
Our previous biochemical data indicate that in the MT/Ves fraction NDPK is not
associated directly with microtubules [28], given that when the polymerization of tubulin
with taxol was performed after membranes have been removed by centrifugation at
230,000 xg, NDPK was absent from the microtubular pellet [28]. This lack of direct
interaction between NDPK and microtubules is in agreement with observations by others
[37,

38].

Analysis

of

the

taxol-stabilized

MT/Ves

fraction

by

confocal

immunofluorescence and DIC confirms this idea. MT/Ves pellets isolated from NIH-3T3
cells were placed on polylysine-coated coverslips, and processed for indirect
immunofluorescence using an antibody to NDPK. As shown in Figure 3, NDPK localizes
to numerous structures of varied size and shape, most of them organized in linear arrays
along the microtubules that are clearly visible in the corresponding DIC image. Similar
DIC images have been obtained with microtubules polymerized with taxol from purified
tubulin [39, 40]. The heterogeneity of the vesicles and their irregular distribution along
the microtubules is typical of similar fractions obtained from hepatocytes [25, 26] and
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3T3-L1 adipocytes [27] by the same protocol utilized here. Thus, transmission electron
microscopy of this fraction has revealed microtubules with many vesicles of variable size
and appearance attached along their lengths [25, 26].

Inspection of Figure 3 also

demonstrates that NDPK localizes to nearly all of the vesicular structures visible in the
DIC image. The widespread distribution of NDPK seen in experiments like the one in
Figure 3 suggests that it binds to a universal component of intracellular membranes,
namely lipids. This would agree with recent results showing that NDPKs A and B bind to
acidic phospholipids [19, 24]. Thus, our next step was to determine whether nucleotides
affect the direct association of NDPK with lipids.
3.5. NDPK binds to phospholipids in a nucleotide sensitive manner
In preliminary tests we used a protein lipid overlay assay. Membrane strips prespotted with different phospholipids were incubated with cytosol from NIH-3T3 cells, as
well as purified NDPKs, and then probed with antibodies against NDPK. Figure 4
illustrates the results obtained with rNDPK A, in the presence and absence of GTP. The
enzyme displays a preference for PtdIns(5)P, PtdIns(3)P, PtdIns(4)P, PtdIns and PS.
When GTP is added, the binding of rNDPK A to all these phospholipids is decreased, but
the extent of the GTP-induced reduction varies from 66% (PS) to 35% (PtdIns(3)P) of the
control value. The enzyme from cytosol also binds to PS and phosphoinositides, albeit
with a slightly distinct selectivity (not shown). There was no detectable binding of murine
or human NDPK to immobilized PC, PE, sphingosine phosphate or lysophospholipids.
Although this type of assay does not necessarily reflect binding affinity or specificity in
solution, and sometimes fails to detect all the phospholipids to which a protein actually
binds [41], it is clear from Figure 4 that purified recombinant NDPK A can bind to pure
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phospholipids, as reported by Tokarska-Schlattner et al. [24], and does so in a GTPsensitive manner.
We then examined how the nucleotide-sensitive binding of NDPK to pure lipids
translated into a more physiological experimental system, that is, liposomes, using a
sedimentation method [42]. Briefly, NDPK from cytosol was incubated with sucroseloaded small unilamellar vesicles of defined phospholipid composition. The samples
were pelleted by ultracentrifugation and the level of NDPK bound to the liposomes was
measured as in Methods. Figure 5 shows that cytosolic NDPK from NIH-3T3 bound to
liposomes of different compositions, showing a preference for PA-containing mixes.
There was negligible binding to liposomes made of pure PC (not shown). This result is in
agreement with the finding that purified NDPK A and B prefer anionic to neutral
phospholipids [19, 24]. More importantly, in the presence of 1mM GTP (or ATP), the
levels of cytosolic NDPK associated with liposomes were noticeably reduced. Similar
results were obtained with purified eNDPK (Fig. 5, lower panel) and rNDPK A (not
shown): the purified proteins bound to several combinations of phospholipids, and the
binding was decreased by 1 mM GTP or ATP. Note that the last step of the purification
procedures for both rNDPK A and eNDPK involves elution of the enzyme from a dye
column with ATP; as a result, both preparations are likely to be partially phosphorylated
[43] and therefore able to associate with liposomes in the absence of added NTP.
Taken together, these findings imply that the mechanism of binding to the
liposomes and to the MT/Ves isolated from cells is essentially the same. Furthermore, the
results shown in Figures 4 and 5 (lower panel) demonstrate conclusively that the
nucleotide-sensitive binding of NDPK to intracellular membranes can be reconstituted
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with a minimal set of components, namely purified enzyme and lipids.
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4. DISCUSSION
Our results confirm recent work [19, 24] showing that soluble NDPKs can
associate with membranes by binding directly to lipids. The interaction does not require
additional proteins, although it is conceivable that it might be strengthened by additional
interactions with other membrane components. Also, the data suggest that the form with
highest affinity for lipids is the phosphoenzyme. Therefore, the equilibrium between
membrane-bound and soluble NDPK will be determined by the availability of the
phosphorylated enzyme.
The equilibrium constant of reaction (a),
[E~P][NDP]  [E][NTP]
lies in the range of 0.15 to 0.5 for NDPKs of various species (reviewed in [44]). The
concentration of ATP in vivo exceeds those of other NTPs, so [NTP]/[NDP] is
approximately equal to the [ATP]/[ADP] ratio, which in most cells, including NIH-3T3
fibroblasts [45], is around 10. Under these conditions, the ratio [E~P]/[E] is 1.5-5,
allowing the binding of NDPK to membranes.
Because of the ping-pong mechanism of NDPK (Figure 6), NDPs not only
dephosphorylate E~P, but also bind to the free enzyme, E, acting as dead end inhibitors
[3]. In either case, if E~P is the form that associates with membranes, NDPs, in this case
ADP, should inhibit binding at all concentrations, either by removing free enzyme
available for phosphorylation, or by dephosphorylating E~P, and this is what is seen in
Figure 2.
NDPK’s Km for ATP is 0.3 mM, one order of magnitude lower than the Ki for dead
end inhibition, 3 mM [3]. Thus, the binding of NTPs to E~P forming abortive complexes
(E~P∙NTP) (Figure 6) is only observed at very high concentrations of NTP, and in the
20

absence of significant amounts of NDPs. This explains the progressive reduction in the
amounts of NDPK associated with membranes as the concentration of ATP (and GTP) is
raised. The marked difference in the behavior of phosphorylating (ATP, GTP) and nonphosphorylating (GTPS) nucleotides is a result of the balance between phosphorylation
and inhibition, which is significant for the natural nucleotides, but is heavily biased
towards inhibition in the case of the thio-modified nucleotide.
Two critical questions remain: where does the lipid bind, and how is the catalytic
cycle of NDPK coupled to the association and dissociation from membranes? The 3D
structures of hexameric NDPK show a symmetrical arrangement that can be described as
two identical trimers superimposed horizontally, forming a disk with a diameter of 70Ǻ
and a thickness of 50Ǻ (reviewed in [46]). There is a single nucleotide-binding site per
subunit, and the top and bottom surfaces of the disk contain three active sites each. The
binding site lies in a crevice lined with basic residues, between a loop and a hairpin
formed by helices A and 2. Preliminary studies using in silico docking indicate that
this site might accomodate a phospholipid such as PA. In this aspect NDPK is
reminiscent of the phosphatidylethanolamine-binding protein (PEBP), a 23 kDa basic
protein that binds phospholipids as well as GTP [47]. Similarly to NDPK, in the crystal
structure of PEBP the ligand binding site lies in a narrow crevice near the surface,
proximal to a strip of basic residues. Like NDPK, the bovine PEBP structure is not
related to other nucleotide binding proteins, or to known lipid-binding proteins. Notably,
the loop connecting helices A and 2 contains the conserved basic residues K56 and
R58, newly identified as essential for the binding of NDPK B to acidic phospholipids
[19]. A previous, groundbreaking report by Epand et al. [48] demonstrated novel
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properties of the mitochondrial NDPK isoform, NDPK D (or NM23-H4), namely the
ability to cross-link bilayers and transfer lipids between them, provided that cardiolipin is
present. These observations were recently expanded by Tokarska-Schlattner et al. [24],
who demonstrated that NDPK-D binds strongly to other acidic phospholipids as well, and
that residue R90 (D57 in NDPKs A and B) from the same loop is essential for the binding
of NDPK-D to artificial and native membranes. Additionally, results from Orlov et al.
[21] are consistent with an involvement of the A-2 hairpin in the association process.
Briefly, a synthetic peptide with a sequence that encompasses helix A dissociates
NDPK B from rod outer segment membranes, whereas peptides homologous to other
portions of the protein have no effect.
There are no detectable differences between the 3D structures of the
phosphorylated NDPK and the free enzyme [49], but binding of nucleotides to the active
site results in a small conformational change, where the A-2 hairpin moves 2Ǻ and
locks the nucleotide in place. This suggests a mechanism by which the conformational
change associated with nucleotide binding could trigger dissociation of NDPK from
bilayers: in E~P, the nucleotide binding site is in the "open" conformation, allowing its
binding to phospholipids, while occupation of the site, followed or not by phosphate
transfer to NDP, closes the cleft and releases the enzyme from the lipid. Soluble NDPK is
eventually rephosphorylated by NTP, and is again capable of associating with membrane
lipids.
In conclusion, our present studies suggest that in vivo the high [ATP]/[ADP] ratio
promotes phosphorylation of NDPK and its association with membranes, where it could
transfer phosphate to locally generated NDPs. Schneider et al. [50] suggested that
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because of its high concentration in the cytosol and the expected prevalence of its
phosphorylated state at normal [ATP]/[ADP] ratios, soluble NDPKs could serve as a
cellular reservoir of high energy phosphate. Targeting of such a reservoir to membranes
may be relevant to the operation of the pathways of phospholipid synthesis, which require
CTP (reviewed in [51]), as well as the multiple GTPases that control intracellular
membrane transport.
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FIGURE LEGENDS
Figure 1- NDPK-B is the major protein dissociated from membranes by GTP, and
behaves as a hexamer, without associated proteins.
A. MT/Ves pellets were washed twice with MEPS (containing protease inhibitors
and 20 M taxol), and then incubated in the same buffer in the absence (Ctr) or presence
of 1 mM GTP. After centrifugation for 30 min at 4°C the supernatants were processed for
SDS-PAGE, resolved in a 12% NuPage gel and stained with silver. B. Immunoblot
analysis of the control (C) and GTP extracts obtained as above, as well as whole cell
lysates (L) from NIH-3T3 cells, with antibodies specific to NDPK-A (Anti-A), NDPK-B
(Anti-B) and polyclonal antibodies to NDPK-C (Anti-C). C. GTP extracts were obtained
as above and fractionated on Superose 12 as described in Methods. Fractions were
assayed for NDPK activity. The elution positions of standards are indicated by (in kDa):
a, 158; b, 67; c, 35, and d, 12.4. D. Immunoblot of column fractions from C with
antibodies to NDPK B (Anti-B). Results shown are representative of 5 independent
experiments.

Figure 2- The interaction of NDPK with membranes is controlled by its substrates, and is
abolished by ATP depletion.
A. Nucleotides were present during taxol-induced polymerization of microtubules
at the concentrations indicated. The amounts of NDPK in the resulting MT/Ves pellets
were assessed as in Methods. Values shown are ratios of the amounts of NDPK in
nucleotide-treated samples to those measured in controls run in parallel with no added
nucleotides, expressed as percent of control. n = 2-3 for GTPS and GDPS, and 3-9 for
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ATP, GTP and ADP. Error bars indicate S.E. of means. B. Cells were kept in low glucose
medium (4 samples) or treated with deoxyglucose and azide (D/A; 2 samples) as in
Methods. Following polymerization with taxol and centrifugation, supernatants (Ctr SN,
D/A SN) were removed and pellets were washed twice. Three Ctr samples were extracted
with 1 mM GTP and pelleted (GTP pellet). Pellets were then resuspended as follows: one
each of Ctr, D/A, and GTP pellets in MEPS buffer (-), one each of D/A and GTP pellets
in Ctr SN, and one GTP pellet in D/A SN. After 30 min on ice, samples were centrifuged
and the pellets were analyzed by SDS-PAGE followed by immunoblotting with
antibodies to NDPK B (Anti-B). Results are representative of 3 experiments.

Figure 3- NDPK localizes to most vesicular structures associated with microtubules.
Samples were prepared as in Methods; the antibody to NDPK was Ab-1. Left
panel: Confocal immunofluorescence of MT/Ves pellets showing localization of NDPK
(red) to many vesicular structures of varying sizes and shapes that are often distributed
along linear tracks. Right panel: the corresponding DIC image demonstrates that most of
these vesicles are associated with the underlying microtubular network. Comparison of
the two panels reveals that nearly all the vesicles seen in the DIC image contain NDPK.

Figure 4- rNDPK A binds to immobilized phospholipids in a GTP-sensitive manner.
PIP strips were incubated with purified rNDPK A as described in Methods, in
the presence and absence of 1 mM GTP, and the bound protein was detected with
antibodies to NDPK A (Anti-A). The location of each lipid is shown in the diagram on
the right. Abbreviations are: S1P, sphingosine-1-phosphate; LPA, lysophosphatidic acid;
PtdIns(3,4)P2, phosphatidylinositol (3,4) bisphosphate; LPC, lysophosphocholine;
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PtdIns(3,5)P2, phosphatidylinositol (3,5) bisphosphate; PtdIns, phosphatidylinositol;
PtdIns(4,5)P2, phosphatidylinositol (4,5) bisphosphate; PtdIns(3)P, phosphatidylinositol
(3) phosphate; PtdIns(3,4,5)P3, phosphatidylinositol (3,4,5) trisphosphate; PtdIns(4)P,
phosphatidylinositol
phosphatidylinositol

(4)

phosphate;

(5)

PA,

phosphate;

phosphatidic
PS,

acid;

PtdIns(5)P,

phosphatidylserine;

PE,

phosphatidylethanolamine; PC, phosphatidylcholine.

Figure 5- Interaction of NDPK from cytosol and purified eNDPK with liposomes of
defined composition.
Liposomes were incubated with cytosol from NIH-3T3 cells (upper panel) or with
purified eNDPK (lower panel) as described in Methods, centrifuged, and washed with
buffer alone or buffer containing 1 mM GTP. The bound protein was detected by SDSPAGE and immunoblotting with Anti-nm23 H1/2/3. Abbreviations are: PC:
dioleylphosphatidylcholine,

PE:

dioleylphosphatidylethanolamine,

PS:

dioleylphosphatidylserine and PA: 1,2-dioleoyl-sn-glycero-3-phosphate. The bar graph
shows the average band intensity measured in 4 experiments, normalized to protein.
Error bars are S. E. of means.

Figure 6- Scheme of NDPK-catalyzed phosphate transfer in the presence of
phospholipids (Cleland notation).
E: free enzyme; EN1TP: enzyme-substrate (nucleoside triphosphate1) complex;
E~PN1DP: phosphorylated enzyme-product (nucleoside diphosphate1) complex; E~P:
phosphorylated enzyme intermediate; E~PN2DP: phosphorylated enzyme-substrate
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(nucleoside diphosphate2) complex; EN2TP: enzyme-substrate (nucleoside triphosphate2)
complex; ENDP, E~PNTP: dead-end complexes formed at high concentrations of NDP
or NTP; E~PLipid: proposed phosphorylated enzyme-phospholipid complex.
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